Free triiodothyronine: A novel predictor of postoperative atrial fibrillation

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 4, 2003, Pages 487-492

  Cerillo, Alfredo Giuseppe ^a   Bevilacqua, Stefano ^a   Storti, Simona ^a   Mariani, Massimiliano ^a   Kallushi, Enkel ^a   Ripoli, Andrea ^a   Clerico, Aldo ^a   Glauber, Mattia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atrial fibrillation; Coronary artery bypass grafting; Thyroid hormone

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HORMONE DETERMINATION; HORMONE METABOLISM; HOSPITAL ADMISSION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; SINUS RHYTHM; SURGICAL TECHNIQUE; THYROID DISEASE; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 0141738631     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00396-8     Document Type: Article

References (24)

1. Hogue C.W., Hyder M.L. Atrial fibrillation after cardiac operation: risks, mechanisms and treatment. Ann Thorac Surg. 69:2000;300-306.
2. Hill L.L., Kattapuram M., Hogue C.W. Management of atrial fibrillation after cardiac surgery - Part I: pathophisiology and risks. J Cardiothorac Vasc Anesth. 16:2002;483-494.
3. Zaman A.G., Archbold R.A., Helft G., Paul E.A., Curzen N.P., Mills P.G. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 101:(12):2000;1403-1408.
4. Ascione R., Caputo M., Calori G., Lloyd C.T., Underwood M.J., Angelini G.D. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation. 102:(13):2000;1530-1535.
5. Aranki S.F., Shaw D.P., Adams D.H., Rizzo R.J., Couper G.S., VanderVliet M., Collins J.J. Jr, Cohn L.H., Burstin H.R. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 94:(3):1996;390-397.
6. Klemperer J.D., Klein I.L., Ojamaa K., Helm R.E., Gomez M., Isom O.W., Krieger K.H. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 61:(5):1996;1323-1329.
7. Klein I., Ojamaa K. Mechanism of disease: thyroid hormone and the cardiovascular system. N Engl J Med. 344:2001;501-509.
8. Iervasi G., Pingitore A., Landi P., Raciti M., Ripoli A., Scarlattini M., L'Abbate A., Donato L. Low-T3 syndrome. A strong prognostic predictor of death in patients with heart disease. Circulation. 107:2003;708-713.
9. i of human cardiomyocytes in culture. Cardiovasc Res. 51:2001;322-330.
10. Nattel S., Khairy P., Schram G. Arrhytmogenic ionic remodeling. Adaptive responses with maladaptive consequences. Trends Cardiovasc Med. 11:2001;295-301.
11. Allessie M.A., Boyden P.A., Camm A.J., Kleber A.G., Lab M.J., Legato M.J., Rosen M.R., Schwartz P.J., Spooner P.M., Van Wagoner D.R., Waldo A.L. Pathophysiology and prevention of atrial fibrillation. Circulation. 103:2001;769-777.
12. Cerillo A.G., Sabatino L., Bevilacqua S., Farneti P.A., Scarlattini M., Forini F., Glauber M. Non-thyroidal illness syndrome in off-pump coronary artery bypass grafting. Ann Thorac Surg. 75:2003;82-87.
13. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 44:1988;837-845.
14. Platt R.W., Hanley J.A., Yang H. Bootstrap confidence intervals for sensitivity of a quantitative diagnostic test. Statist Med. 19:2000;313-322.
15. Klemperer J.D., Klein I., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., Isom O.W., Krieger K. Thyroid hormone treatment after coronary-artery bypass surgery. N Eng J Med. 333:1995;1522-1527.
16. Mullis-Jansson S.L., Argenziano M., Corwin S., Homma S., Weinberg A.D., Williams M., Rose E.A., Smith C.R. A randomised double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg. 117:1999;1128-1135.
17. Wartofsky L., Burman K.D., Ringel M.D. Trading one 'Dangerous dogma' for another? Thyroid hormone treatment of the 'Euthyroid sick syndrome'. J Clin Invest Metab. 84:1999;1759-1760.
18. 2+ adenosine triphosphatase gene is increased by 3,5,3′-triiodothyronine receptor isoform-specific interactions with the myocyte-specific enhancer factor-2a. Endocrinology. 138:1997;26-32.
19. Rubinstein I., Binah O. Thyroid hormone modulates membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol. 340:1989;705-711.
20. Bosch R.F., Wang Z., Li G.R., Nattel S. Electrophysiological mechanisms by which hypothyroidism delays repolarization in guinea pig hearts. Am J Physiol. 277:1999;211-220.
21. De Groot L.J. Dangerous dogmas in medicine: the non-thyroidal illness syndrome. J Clin Endocrinol Metab. 84:1999;151-164.
22. Crystal E., Connolly S.J., Sleik K., Ginger T.J., Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. A meta-analysis. Circulation. 106:2002;75-80.
23. Broderick T.J., Wechsler A.S. Triiodothyronine in cardiac surgery. Thyroid. 7:1997;133-137.
24. Holland F.W., Brown P.S., Weintraub B.D., Clark R.E. Cardiopulmonary bypass and thyroid function: a 'Euthyroid sick syndrome'. Ann Thorac Surg. 52:1991;46-50.